Drug Discovery and Development, edited by M.S. Chorghade, is a two volume set, the first of which is now available. Volume 1, Drug Discovery, is composed of 16 chapters by authors who are active in the field of medicinal chemistry and are able to bring historical perspective to this important field
Nonprofit model for drug discovery and development
โ Scribed by Gregory Daniel Frank; Ling Jong; Nathan Collins; Edward G. Spack
- Publisher
- John Wiley and Sons
- Year
- 2007
- Tongue
- English
- Weight
- 521 KB
- Volume
- 68
- Category
- Article
- ISSN
- 0272-4391
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
## Abstract The development of novel drugs is becoming increasingly challenging, inefficient, and costly, as acknowledged by all major stakeholders of pharmaceutical products. Adaptive designs have attracted considerable attention in recent years, as they promise an increase in efficiency of the dr
## Abstract A fundamental goal of chemical proteomics is to identify target proteins for bioactive small molecules and then apply them to drug discovery and development as valid and drugable targets. Here, we introduce integrated technologies for the rapid identification of target proteins, methodo
## Abstract Metabolism by the host organism is one of the most important determinants of the pharmacokinetic profile of a drug. High metabolic lability usually leads to poor bioavailability and high clearance. Formation of active or toxic metabolites will have an impact on the pharmacological and t